Principal Financial Group Inc Vanda Pharmaceuticals Inc. Transaction History

Principal Financial Group Inc

$172 Billion
Q4 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$3.38 - $4.58 $17,947 - $24,319	5,310 Added 20.85%	30,774 $129,000
Q3 2023 Nov 02, 2023	SELL	$4.28 - $6.57 $1.34 Million - $2.05 Million	-311,998 Reduced 92.45%	25,464 $110,000
Q2 2023 Aug 07, 2023	SELL	$5.9 - $6.95 $78,505 - $92,476	-13,306 Reduced 3.79%	337,462 $2.22 Million
Q1 2023 May 09, 2023	SELL	$6.18 - $7.99 $30,325 - $39,206	-4,907 Reduced 1.38%	350,768 $2.38 Million
Q4 2022 Feb 09, 2023	SELL	$6.87 - $10.96 $41,975 - $66,965	-6,110 Reduced 1.69%	355,675 $2.63 Million
Q3 2022 Nov 09, 2022	SELL	$9.44 - $11.76 $225,927 - $281,452	-23,933 Reduced 6.2%	361,785 $3.58 Million
Q2 2022 Aug 10, 2022	SELL	$9.31 - $11.84 $137,843 - $175,303	-14,806 Reduced 3.7%	385,718 $4.21 Million
Q1 2022 May 09, 2022	SELL	$10.84 - $16.55 $217,873 - $332,638	-20,099 Reduced 4.78%	400,524 $4.53 Million
Q4 2021 Feb 09, 2022	SELL	$15.69 - $21.14 $391,198 - $527,083	-24,933 Reduced 5.6%	420,623 $6.6 Million
Q3 2021 Nov 09, 2021	SELL	$15.35 - $21.27 $80,372 - $111,369	-5,236 Reduced 1.16%	445,556 $7.64 Million
Q2 2021 Aug 10, 2021	SELL	$15.71 - $21.51 $7,367 - $10,088	-469 Reduced 0.1%	450,792 $9.7 Million
Q1 2021 May 10, 2021	BUY	$13.42 - $20.28 $89,108 - $134,659	6,640 Added 1.49%	451,261 $6.78 Million
Q4 2020 Feb 08, 2021	BUY	$9.77 - $13.81 $488,392 - $690,348	49,989 Added 12.67%	444,621 $5.84 Million
Q3 2020 Nov 06, 2020	SELL	$9.32 - $12.02 $132,577 - $170,984	-14,225 Reduced 3.48%	394,632 $3.81 Million
Q2 2020 Aug 05, 2020	SELL	$9.66 - $12.02 $39,779 - $49,498	-4,118 Reduced 1.0%	408,857 $4.68 Million
Q1 2020 May 12, 2020	SELL	$7.5 - $16.8 $121,447 - $272,042	-16,193 Reduced 3.77%	412,975 $4.28 Million
Q4 2019 Feb 05, 2020	BUY	$12.38 - $17.47 $111,172 - $156,880	8,980 Added 2.14%	429,168 $7.04 Million
Q3 2019 Nov 13, 2019	SELL	$12.27 - $15.79 $56,331 - $72,491	-4,591 Reduced 1.08%	420,188 $5.58 Million
Q2 2019 Aug 12, 2019	SELL	$13.37 - $18.85 $83,722 - $118,038	-6,262 Reduced 1.45%	424,779 $5.99 Million
Q1 2019 May 10, 2019	SELL	$17.59 - $31.05 $40,439 - $71,383	-2,299 Reduced 0.53%	431,041 $7.93 Million
Q4 2018 Feb 14, 2019	SELL	$18.97 - $31.47 $150,033 - $248,896	-7,909 Reduced 1.79%	433,340 $11.3 Million
Q3 2018 Nov 14, 2018	BUY	$18.25 - $23.0 $8.05 Million - $10.1 Million	441,249 New	441,249 $10.1 Million
Q4 2017 Feb 13, 2018	SELL	$12.85 - $18.1 $2.75 Million - $3.87 Million	-213,898 Closed	0 $0
Q3 2017 Nov 02, 2017	BUY	$15.4 - $18.85 $3.29 Million - $4.03 Million	213,898	213,898 $3.83 Million

Others Institutions Holding VNDA

# of Institutions

156

Shares Held

44.7M

Call Options Held

167K

Put Options Held

33.6K

Black Rock Inc. New York, NY

8.14M
Shares

$39.1 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.01M
Shares

$19.3 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

3.63M
Shares

$17.4 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.35M
Shares

$11.3 Million
0.94% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.26M
Shares

$10.9 Million
0.0% of portfolio

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $271M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account